脑梗死病证结合诊疗方案的临床疗效评价

Clinical Efficacy Evaluation of Therapy of Combined Disease and Syndrome for Treatment of Cerebral Infarction

目的对脑梗死病证结合诊疗方案的实施进行临床疗效评价。方法随机对160例脑梗死患者在治疗前和治疗后4周分别进行日常生活活动能力量表(改良Barthel指数量表)评分、中医证候积分,并根据《中风病诊断和疗效评定标准》进行评分和用尼莫地平法评价。结果实施脑梗死病证结合诊疗方案治疗的患者疗效显著,中医证候积分、MBI评分改善显著(P<0.05)。结论实施脑梗死病证结合诊疗方案,对中风症状的近期改善效果满意。

Objective To evaluate the clinical effect of therapy of Combined Disease and Syndrome on cerebral infarction. Methods One hundred and sixty patients with cerebral infarction were treated by therapy of disease and syndrome. Patients were evaluated with MBI scores, traditional Chinese medicine（TCM） symptom scores, Stroke Diagnosis and Curative Effect Standard,and Nimodipine Method before the treatment at 4 weeks after treatment. Results The therapy regimen was effective. Symptom scores and MBI scores were improved following this therapy （P〈0. 05）. Conclusion Therapy of combined disease and syndrome was effective for the treatment of cerebral infarction.